Drug Development Market Scope And Analysis

  • Report Code : TIPRE00024322
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Markttrends in der Arzneimittelentwicklung, Umfangsanalyse bis 2025-2031

Buy Now

Drug Development Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 9.2%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Arzneimitteltyp
  • kleinmolekulare Arzneimittel
  • biologische Arzneimittel
By Technologie
  • Hochdurchsatz-Screening
  • Pharmakogenomik
  • Kombinatorische Chemie
  • Nanotechnologie
  • andere Technologien
By Endverbraucher
  • Pharmaunternehmen
  • Auftragsforschungsinstitute
  • sonstige Endverbraucher
By Geographie
  • Nordamerika
  • Europa
  • Asien-Pazifik
  • Süd- und Mittelamerika
  • Naher Osten und Afrika
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Genome Biologics
  • Abbott Laboratories Inc.
  • Agilent Technologies Inc.
  • AstraZeneca PLC
  • AVIVA Biosciences
  • Bayer AG
  • Biotica Pharma.
  • Bristol-Myers Squibb Company
  • Collaborative Drug Discovery Inc.